About the Cancer Of The Eye Session
Ocular cancer, commonly referred to as eye cancer, represents a relatively uncommon yet formidable challenge in the realm of oncological research. Delving into the intricate mechanisms underlying its onset and progression, scientists probe the interplay between genetic predispositions, environmental triggers, and lifestyle influences. Cutting-edge imaging technologies facilitate early identification, enhancing prognosis and treatment outcomes. From targeted drug therapies to the promising frontier of immunomodulation, the therapeutic landscape is expanding, offering renewed hope for patients. Interdisciplinary collaboration among oncologists, ophthalmologists, and researchers remains pivotal in deciphering ocular cancer's complexities, driving forward strides in prevention, diagnosis, and tailored intervention strategies.
Topics Covered in Cancer Of The Eye
Uveal Melanoma
Retinoblastoma
Vitreoretinal Lymphoma
Conjunctival Tumors
Ocular Metastases
Plaque Radiotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Of The Eye Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Of The Eye work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Of The Eye research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Of The Eye track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Of The Eye Conference 2027 — FAQs
What is the Cancer Of The Eye track at CIOC 2027?
The Cancer Of The Eye track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Of The Eye. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Of The Eye sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Of The Eye are all welcome — whether presenting or attending.
Can I present my research in the Cancer Of The Eye track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Of The Eye sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Of The Eye track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.